Law channel feed – Endpoints News

Law channel feed

Novo and Viatris settle Ozempic patent suit as generic entry date remains unknown

7 months ago

Many drug price proposals from candidates and Congress won't have much effect, analysis finds

7 months ago

Supreme Court declines to review patent battle over inhalation powder Yutrepia

7 months ago

Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine

8 months ago

AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law

8 months ago

Updated: Senators question FDA and FTC over patent and PBM reforms

8 months ago

Judge keeps Amgen's $10.7B tax liability suit alive

8 months ago

Federal judge dismisses longstanding suit over Bristol Myers' $74B Celgene buyout

8 months ago

J&J pulls the plug on 340B rebate model changes opposed by government

8 months ago

US government renews threats over J&J's proposed 340B rebate model

8 months ago

Cassava and its former execs settle SEC charges for ‘misleading’ Alzheimer’s drug data

8 months ago

Baltimore sues Biogen, saying the company colluded with PBMs to minimize generic competition

8 months ago

Federal judge rules against Regeneron's attempt to halt Amgen from launching Eylea biosimilar

8 months ago

House passes reauthorization of rare pediatric voucher program

8 months ago

A small startup is challenging Epic's control over patient health records

8 months ago

J&J subsidiary files for third bankruptcy to settle talc claims

8 months ago

Sen. Cassidy questions Lilly and Amgen on 340B restrictions on contract pharmacies

8 months ago

The drug lobby's lawsuit against the IRA finds a sign of life after appeals court ruling

8 months ago

J&J will defend its proposed 340B changes as US threatens penalties

8 months ago

FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost

8 months ago

Cigna sues FTC, calling for withdrawal of 'biased, erroneous' PBM report

8 months ago

SEC probe of Illumina’s Grail deal targets sales forecasts, sources say

8 months ago

After a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penalty

8 months ago

CVS says it won't correct congressional testimony

8 months ago

First page Previous page 5 6 789 10 11 Next page Last page